|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash ($1,108 related to consolidated VIEs as of December 31, 2025) | ||||||||||||||||||||
| Loans held for investment ($138,950 related to consolidated VIEs as of December 31, 2025) | ||||||||||||||||||||
| Real estate owned held for investment, net ($52,634 related to consolidated VIEs as of December 31, 2025) | ||||||||||||||||||||
| Current expected credit loss reserve | ||||||||||||||||||||
| Loans held for investment, net of current expected credit loss reserve | ||||||||||||||||||||
| Loans held for sale ($38,981 related to consolidated VIEs as of December 31, 2023) | ||||||||||||||||||||
| Investment in available-for-sale debt securities, at fair value | ||||||||||||||||||||
| Real estate owned held for investment, net | ||||||||||||||||||||
| Unfunded comments, held for sale | ||||||||||||||||||||
| Real estate owned held for sale | ||||||||||||||||||||
| Other assets ($76 of interest receivable related to consolidated VIEs as of December 31, 2025) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Secured funding agreements | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Secured term loan | ||||||||||||||||||||
| Collateralized loan obligation securitization debt (consolidated VIEs) | ||||||||||||||||||||
| Due to affiliate | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Other liabilities ($257 of interest payable related to consolidated VIEs as of December 31, 2025) | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total other liabilities ($257 of interest payable related to consolidated VIEs as of December 31, 2025) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Common stock, par value $0.01 per share, 450,000,000 shares authorized at June 30, 2026 and December 31, 2025 and 55,481,113 and 55,026,453 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Accumulated earnings (deficit) | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
